AQP4 and Parkinson disease: A potential involvement of the glymphatic system within Parkinson’s disease can also be derived from the multifaceted role of the affected neurotransmitter, dopamine, as the cholinergic monoamine transmitter was shown to both mediate ISF influx and directly modulate glial differentiation and AQP4 expression [30,31].